CMS has completed two negotiation cycles so far: the first set of 10 drugs took effect in 2026, and a second set of 15 drugs, including Ozempic and Wegovy, takes effect in 2027.
Ironically, it is the unprecedented success of these medications that has the team worried
Right now, retatrutide has not crossed that approval line
In addition, some pivotal bone turnover biomarkers are not included in the NHANES database, such as procollagen type 1 N-terminal propeptide, osteocalcin, carboxy-terminal cross-linked telopeptide of type 1 collagen, amino-terminal cross-linked telopeptide of type 1 collagen, and so on, which impedes us to perform more detailed and specific analyses
Maybe some mild redness that disappears within an hour
Mayo Clinic reports that semaglutide medications, like Wegovy , do begin to work on appetite control relatively soon after use as quickly as the first week